AMN Healthcare Services, Inc. AMN is still struggling with the normalization of nurse staffing post-pandemic. This Zacks Rank #5 (Strong Sell) is expected to see earnings decline another 61% this year.
AMN, ARCB and ARW have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2023.
There are good reasons to believe AMN Healthcare can resume its impressive business performance once the post-pandemic reset in its core market comes to an end. There are several long-term fundamental value drivers over the next decade if the company can execute. The near-term picture remains murky, but insider buying suggests the stock might not have much further to fall. It could offer an attractive risk/reward at these levels.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.